We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
- Authors
Ajani, Jaffer A; Moiseyenko, Vladimir M; Tjulandin, Sergei; Majlis, Alejandro; Constenla, Manuel; Boni, Corrado; Rodrigues, Adriano; Fodor, Miguel; Chao, Yee; Voznyi, Edouard; Awad, Lucile; Van Cutsem, Eric; V-325 Study Group
- Abstract
Therapy of patients with advanced gastric or gastroesophageal junction cancer should provide symptom relief and improve quality of life (QOL) because most patients are symptomatic at baseline. Using validated instruments, we prospectively assessed QOL (even after completion of protocol treatment) as one of the secondary end points of the V325 phase III trial.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 22, p3210
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.08.3956